Features of natural and gonadotropin-releasing hormone antagonist-induced corpus luteum regression and effects of in vivo human chorionic gonadotropin

被引:32
|
作者
Del Canto, Felipe
Sierralta, Walter
Kohen, Paulina
Munoz, Alex
Strauss, Jerome F., III
Devoto, Luigi
机构
[1] Univ Chile, Fac Med, Inst Invest Materno Infantil, Hosp Clin San Borja Arriaran, Santiago 3, Chile
[2] Univ Chile, INTA, Lab Ultraestruct, Santiago 3, Chile
[3] Virginia Commonwealth Univ, Sch Med, Dept Obstet & Gynecol, Richmond, VA USA
来源
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2007年 / 92卷 / 11期
关键词
D O I
10.1210/jc.2007-0125
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: The natural process of luteolysis and luteal regression is induced by withdrawal of gonadotropin support. Objective: The objectives of this study were: 1) to compare the functional changes and apoptotic features of natural human luteal regression and induced luteal regression; 2) to define the ultrastructural characteristics of the corpus luteum at the time of natural luteal regression and induced luteal regression; and 3) to examine the effect of human chorionic gonadotropin ( hCG) on the steroidogenic response and apoptotic markers within the regressing corpus luteum. Design: Twenty- three women with normal menstrual cycles undergoing tubal ligation donated corpus luteum at specific stages in the luteal phase. Some women received a GnRH antagonist prior to collection of corpus luteum, others received an injection of hCG with or without prior treatment with a GnRH antagonist. Main Outcome Measure: Main outcome measures were plasma hormone levels and analysis of excised luteal tissue for markers of apoptosis, histology, and ultrastructure. Results: The progesterone and estradiol levels, corpus luteum DNA, and protein contents in induced luteal regression resembled those of natural luteal regression. hCG treatment raised progesterone and estradiol in both natural luteal regression and induced luteal regression. The increase in apoptosis detected in induced luteal regression by cytochrome c in the cytosol, activated caspase- 3, and nuclear DNA fragmentation, was similar to that observed in natural luteal regression. The antiapoptotic protein Bcl- 2 was significantly lower during natural luteal regression. The proapoptotic proteins Bax and Bak were at a constant level. Apoptotic and nonapoptotic death of luteal cells was observed in natural luteal regression and induced luteal regression at the ultrastructural level. hCG prevented apoptotic cell death, but not autophagy. Conclusion: The low number of apoptotic cells disclosed and the frequent autophagocytic suggest that multiple mechanisms are involved in cell death at luteal regression. hCG restores steroidogenic function and restrains the apoptotic process, but not autophagy.
引用
收藏
页码:4436 / 4443
页数:8
相关论文
共 50 条
  • [1] VARIABLE TOLERANCE OF THE DEVELOPING FOLLICLE AND CORPUS-LUTEUM TO GONADOTROPIN-RELEASING-HORMONE ANTAGONIST-INDUCED GONADOTROPIN WITHDRAWAL IN THE HUMAN
    HALL, JE
    BHATTA, N
    ADAMS, JM
    RIVIER, JE
    VALE, WW
    CROWLEY, WF
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 72 (05): : 993 - 1000
  • [2] The Effects of Human Chorionic Gonadotropin and Gonadotropin-Releasing Hormone Receptor Antagonist on Testicular Steroidogenesis in Normal and Obese Rats
    Lebedev, I. A.
    Kuznetsova, V. S.
    Bakhtyukov, A. A.
    Shpakov, A. O.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2024, 177 (04) : 436 - 441
  • [3] Dual trigger with gonadotropin-releasing hormone agonist and recombinant human chorionic gonadotropin improves in vitro fertilization outcome in gonadotropin-releasing hormone antagonist cycles
    Seval, Mehmet Murat
    Ozmen, Batuhan
    Atabekoglu, Cem
    Sukur, Yavuz Emre
    Simsir, Coskun
    Kan, Ozgur
    Sonmezer, Murat
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2016, 42 (09) : 1146 - 1151
  • [4] LACK OF RELEASE OF HUMAN CHORIONIC-GONADOTROPIN BY GONADOTROPIN-RELEASING HORMONE
    TAMADA, T
    AKABORI, A
    KONUMA, S
    ARAKI, S
    ENDOCRINOLOGIA JAPONICA, 1976, 23 (06): : 531 - 533
  • [5] EFFECT OF HUMAN CHORIONIC-GONADOTROPIN AND GONADOTROPIN-RELEASING HORMONE ON CORPUS-LUTEUM FUNCTION AND ESTROUS-CYCLE DURATION IN DAIRY HEIFERS
    SEGUIN, BE
    OXENDER, WD
    BRITT, JH
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 1977, 38 (08) : 1153 - 1156
  • [6] A cellular and endocrine characterization of the original and induced corpus luteum after administration of a gonadotropin-releasing hormone agonist or human chorionic gonadotropin on day five of the estrous cycle
    Schmitt, EJP
    Barros, CM
    Fields, PA
    Fields, MJ
    Diaz, T
    Kluge, JM
    Thatcher, WW
    JOURNAL OF ANIMAL SCIENCE, 1996, 74 (08) : 1915 - 1929
  • [7] In vivo responses of the primate corpus luteum to luteinizing hormone and chorionic gonadotropin
    Zeleznik, AJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (18) : 11002 - 11007
  • [8] GONADOTROPIN-RELEASING HORMONE-INDUCED ALTERATION OF BOVINE CORPUS-LUTEUM FUNCTION
    RODGER, LD
    STORMSHAK, F
    BIOLOGY OF REPRODUCTION, 1986, 35 (01) : 149 - 156
  • [9] Dual trigger with gonadotropin-releasing hormone and human chorionic gonadotropin for poor responders
    Eser, Ahmet
    Devranoglu, Belgin
    Ergen, Evrim Bostanci
    Abide, Cigdem Yayla
    JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION, 2018, 19 (02) : 98 - 103
  • [10] Gonadotropin-releasing hormone/human chorionic gonadotropin β based recombinant antibodies and vaccines
    Talwar, G. P.
    Vyas, Hemant K.
    Purswani, Shilpi
    Gupta, Jagdish C.
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2009, 83 (1-2) : 158 - 163